Gene, Cell and Tissue

Published by: Kowsar

Analysis of HLA-A*03 in Multiple Sclerosis Patients in Khuzestan Province, Iran

Hamid Galehdari 1 , Maryam Mohaghegh 1 , * , Nastaran Majdinasab 2 , Saeid Reza Khatami 1 and Mahshid Hosseini Behbahani 3
Authors Information
1 Department of Genetic, Faculty of Science, Shahid Chamran University, Ahvaz, Iran
2 Department of Neurology, Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Department of Biochemistry, Payame Noor University, Tehran, Iran
Article information
  • Gene, Cell and Tissue: July 2018, 5 (3); e68293
  • Published Online: October 22, 2018
  • Article Type: Research Article
  • Received: March 4, 2018
  • Revised: October 18, 2018
  • Accepted: October 20, 2018
  • DOI: 10.5812/gct.68293

To Cite: Galehdari H, Mohaghegh M, Majdinasab N, Khatami S R , Hosseini Behbahani M. Analysis of HLA-A*03 in Multiple Sclerosis Patients in Khuzestan Province, Iran, Gene Cell Tissue. 2018 ; 5(3):e68293. doi: 10.5812/gct.68293.

Abstract
Copyright © 2018, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Nischwitz S, Muller-Myhsok B, Weber F. Risk conferring genes in multiple sclerosis. FEBS Lett. 2011;585(23):3789-97. doi: 10.1016/j.febslet.2011.03.037. [PubMed: 21439284].
  • 2. Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359(9313):1221-31. doi: 10.1016/S0140-6736(02)08220-X. [PubMed: 11955556].
  • 3. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343(13):938-52. doi: 10.1056/NEJM200009283431307. [PubMed: 11006371].
  • 4. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-52. [PubMed: 6685237].
  • 5. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46(4):907-11. [PubMed: 8780061].
  • 6. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol. 2007;61(4):288-99. doi: 10.1002/ana.21117. [PubMed: 17444504].
  • 7. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol. 2008;7(3):268-77. doi: 10.1016/S1474-4422(08)70042-5. [PubMed: 18275928].
  • 8. Sanfilippo F, Amos DB. An interpretation of the major histocompatibility complex. In: Rose N, Friedman H, Fahey J, editors. Manual of clinical laboratory immunology. 3rd ed. Washington DC: Am Soc Microbiol; 1986.
  • 9. Mackay RP. The familial occurrence of multiple sclerosis and its implications. Ann Intern Med. 1950;33(2):298-320. [PubMed: 15433121].
  • 10. Eichhorst H. [About infantile and hereditary multiple sclerosis]. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 1896;146(2):173-92. German. doi: 10.1007/bf01882681.
  • 11. Lin R, Charlesworth J, van der Mei I, Taylor BV. The genetics of multiple sclerosis. Pract Neurol. 2012;12(5):279-88. doi: 10.1136/practneurol-2012-000276. [PubMed: 22976058].
  • 12. Shankarkumar U. The human leukocyte antigen (HLA) system. Int J Hum Genet. 2004;4(2):91-103. doi: 10.1080/09723757.2004.11885875.
  • 13. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol. 2004;3(2):104-10. [PubMed: 14747002].
  • 14. Paty DW, Mervart H, Campling B, Rand CG, Stiller CR. HL-A frequencies in patients with multiple sclerosis. Can J Neurol Sci. 1974;1(4):211-3. [PubMed: 4441986].
  • 15. Bertrams HJ, Kuwert EK. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis. J Immunol. 1976;117(5 Pt.2):1906-12. [PubMed: 993587].
  • 16. de Moerloose P, Jeannet M, Martins-da-Silva B, Werner-Favre C, Rohr J, Gauthier G. Increased frequency of HLA--DRw2 and DRw3 in multiple sclerosis. Tissue Antigens. 1979;13(5):357-60. [PubMed: 91212].
  • 17. Burfoot RK, Jensen CJ, Field J, Stankovich J, Varney MD, Johnson LJ, et al. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: Searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens. 2008;71(1):42-50. doi: 10.1111/j.1399-0039.2007.00962.x. [PubMed: 17971048].
  • 18. Leon VJ, Cacho JL, Rodriguez-Perez R, Bowakin D. Study of HLA aleles in multiple sclerosis in Castilla y Leon (Spain). Hum Immunol. 2005;66(8):40. doi: 10.1016/j.humimm.2005.08.075.
  • 19. Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens. 2004;63(3):237-47. doi: 10.1111/j.0001-2815.2004.00173.x. [PubMed: 14989713].
  • 20. Kankonkar S, Singhal BS, Shankarkumar U. HLA A, B, Cw. DRB1 and DQB1 alleles in multiple sclerosis patients in India. Int J Hum Genet. 2012;12(1):37-40. doi: 10.1080/09723757.2012.11886160.
  • 21. Bayati A, Ghabaei M, Amir Sarv Kolahi S. A case control study on genetic susceptibility in multiple sclerosis. Iran J Neurol. 2008;7(21):143-52.
  • 22. Sharafaddinzadeh N, Moghtaderi A, Majdinasab N, Dahmardeh M, Kashipazha D, Shalbafan B. The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs. Clin Neurol Neurosurg. 2013;115(8):1271-5. doi: 10.1016/j.clineuro.2012.11.027. [PubMed: 23273383].
  • 23. Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004;3(12):709-18. doi: 10.1016/S1474-4422(04)00933-0. [PubMed: 15556803].
  • 24. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005;4(5):281-8. doi: 10.1016/S1474-4422(05)70071-5. [PubMed: 15847841].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments